| abstract |
The present invention relates to antiviral compounds, compositions comprising such compounds, and therapeutic methods involving the administration of such compounds, as well as processes and intermediates useful for the preparation of such compounds. In one embodiment, the present invention relates to hepatitis C comprising administering to an individual a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt or prodrug thereof. A method for treating a failure is provided. In a further embodiment, the invention comprises administering an amount of a compound of formula I, or a pharmaceutically acceptable salt or prodrug thereof, effective to inhibit HCV to a mammal suffering from a condition associated with HCV. The present invention provides a method for inhibiting HCV. |